CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C15804 | BRD-K42126874 | BRD-K42126874 | -- | -- | -- | Details |
| C15805 | BRD-K42132006 | BRD-K42132006 | -- | -- | -- | Details |
| C15806 | BRD-K42134801 | BRD-K42134801 | -- | -- | -- | Details |
| C15807 | BRD-K42136113 | BRD-K42136113 | -- | -- | -- | Details |
| C15808 | BRD-K42137908 | palmostatin-b | -- | -- | -- | Details |
| C15809 | BRD-K42138859 | BRD-K42138859 | -- | -- | -- | Details |
| C15810 | BRD-K42139332 | BRD-K42139332 | -- | -- | -- | Details |
| C15811 | BRD-K42140106 | VU-0405172-2 | -- | -- | -- | Details |
| C15812 | BRD-K42140123 | BRD-K42140123 | -- | -- | -- | Details |
| C15813 | BRD-K42142217 | BRD-K42142217 | -- | -- | -- | Details |
| C15814 | BRD-K42142750 | retrorsine | -- | -- | -- | Details |
| C15815 | BRD-K42145213 | BRD-K42145213 | -- | -- | -- | Details |
| C15816 | BRD-K42150052 | BRD-K42150052 | -- | -- | -- | Details |
| C15817 | BRD-K42156657 | BRD-K42156657 | -- | -- | -- | Details |
| C15818 | BRD-K42161310 | BRD-K42161310 | -- | -- | -- | Details |
| C15819 | BRD-K42170810 | BRD-K42170810 | -- | -- | -- | Details |
| C15820 | BRD-K42173890 | BRD-K42173890 | -- | -- | -- | Details |
| C15821 | BRD-K42181022 | BRD-K42181022 | -- | -- | -- | Details |
| C15822 | BRD-K42182933 | BRD-K42182933 | -- | -- | -- | Details |
| C15823 | BRD-K42185771 | BRD-K42185771 | -- | -- | -- | Details |
| C15824 | BRD-K42191735 | buparlisib | PIK3CA | PI3K inhibitor | -- | Details |
| C15825 | BRD-K42197878 | BRD-K42197878 | -- | -- | -- | Details |
| C15826 | BRD-K42199095 | BRD-K42199095 | -- | -- | -- | Details |
| C15827 | BRD-K42205652 | BRD-K42205652 | -- | -- | MNS-(3,4-methylenedioxy-nitrostyrene) | Details |
| C15828 | BRD-K42207609 | BRD-K42207609 | -- | -- | -- | Details |
| C15829 | BRD-K42214389 | BRD-K42214389 | -- | -- | -- | Details |
| C15830 | BRD-K42216874 | BRD-K42216874 | -- | -- | -- | Details |
| C15831 | BRD-K42221274 | NNC-711 | SLC6A1 | GAT inhibitor | -- | Details |
| C15832 | BRD-K42232544 | BRD-K42232544 | -- | -- | -- | Details |
| C15833 | BRD-K42241928 | BRD-K42241928 | -- | -- | -- | Details |
| C15834 | BRD-K42245756 | BRD-K42245756 | -- | -- | -- | Details |
| C15835 | BRD-K42247636 | BRD-K42247636 | -- | -- | -- | Details |
| C15836 | BRD-K42251804 | BRD-K42251804 | -- | -- | -- | Details |
| C15837 | BRD-K42253676 | BRD-K42253676 | -- | -- | -- | Details |
| C15838 | BRD-K42256568 | BRD-K42256568 | -- | -- | -- | Details |
| C15839 | BRD-K42260897 | ezetimibe | NPC1L1 | Cholesterol inhibitor; Niemann-Pick C1-like 1 protein antagonist | -- | Details |
| C15840 | BRD-K42269438 | BRD-K42269438 | -- | -- | -- | Details |
| C15841 | BRD-K42271016 | BRD-K42271016 | -- | -- | -- | Details |
| C15842 | BRD-K42279779 | BRD-K42279779 | -- | -- | -- | Details |
| C15843 | BRD-K42296822 | BRD-K42296822 | -- | -- | -- | Details |
| C15844 | BRD-K42303783 | BRD-K42303783 | -- | -- | -- | Details |
| C15845 | BRD-K42307233 | BRD-K42307233 | -- | -- | -- | Details |
| C15846 | BRD-K42308740 | ST-056792 | -- | -- | -- | Details |
| C15847 | BRD-K42333498 | BRD-K42333498 | -- | -- | -- | Details |
| C15848 | BRD-K42348709 | cyclobenzaprine | HTR2A | Serotonin receptor agonist; Adrenergic receptor agonist | -- | Details |
| C15849 | BRD-K42352790 | anandamide | CNR1; CNR2; TRPV1 | Cannabinoid receptor agonist | -- | Details |
| C15850 | BRD-K42357106 | BRD-K42357106 | -- | -- | -- | Details |
| C15851 | BRD-K42359528 | BRD-K42359528 | -- | -- | -- | Details |
| C15852 | BRD-K42361507 | BRD-K42361507 | -- | -- | -- | Details |
| C15853 | BRD-K42361742 | BRD-K42361742 | -- | -- | -- | Details |
| C15854 | BRD-K42361978 | BRD-K42361978 | -- | -- | -- | Details |
| C15855 | BRD-K42363645 | BRD-K42363645 | -- | -- | -- | Details |
| C15856 | BRD-K42363982 | BRD-K42363982 | -- | -- | -- | Details |
| C15857 | BRD-K42365464 | BRD-K42365464 | -- | -- | -- | Details |
| C15858 | BRD-K42367391 | BRD-K42367391 | -- | -- | -- | Details |
| C15859 | BRD-K42379673 | BRD-K42379673 | -- | -- | -- | Details |
| C15860 | BRD-K42383812 | BRD-K42383812 | -- | -- | -- | Details |
| C15861 | BRD-K42385001 | BRD-K42385001 | -- | -- | -- | Details |
| C15862 | BRD-K42392619 | BRD-K42392619 | -- | -- | -- | Details |
| C15863 | BRD-K42393177 | BRD-K42393177 | -- | -- | -- | Details |
| C15864 | BRD-K42394957 | BRD-K42394957 | -- | -- | -- | Details |
| C15865 | BRD-K42397226 | BRD-K42397226 | -- | -- | -- | Details |
| C15866 | BRD-K42400613 | BRD-K42400613 | -- | -- | -- | Details |
| C15867 | BRD-K42400758 | BRD-K42400758 | -- | -- | -- | Details |
| C15868 | BRD-K42411085 | BRD-K42411085 | -- | -- | -- | Details |
| C15869 | BRD-K42413274 | BRD-K42413274 | -- | -- | -- | Details |
| C15870 | BRD-K42417338 | butorphanol-(+)-tartrate | OPRD1; OPRK1; OPRM1 | Opioid receptor agonist; Opioid receptor antagonist | -- | Details |
| C15871 | BRD-K42419294 | BRD-K42419294 | -- | -- | -- | Details |
| C15872 | BRD-K42419992 | BRD-K42419992 | -- | -- | -- | Details |
| C15873 | BRD-K42420111 | BRD-K42420111 | -- | -- | -- | Details |
| C15874 | BRD-K42427050 | BRD-K42427050 | -- | -- | -- | Details |
| C15875 | BRD-K42435091 | BRD-K42435091 | -- | -- | -- | Details |
| C15876 | BRD-K42435237 | BRD-K42435237 | -- | -- | -- | Details |
| C15877 | BRD-K42436189 | AZ-20 | -- | -- | -- | Details |
| C15878 | BRD-K42438139 | BRD-K42438139 | -- | -- | -- | Details |
| C15879 | BRD-K42439884 | BRD-K42439884 | -- | -- | -- | Details |
| C15880 | BRD-K42449328 | BRD-K42449328 | -- | -- | -- | Details |
| C15881 | BRD-K42450605 | BRD-K42450605 | -- | -- | -- | Details |
| C15882 | BRD-K42452249 | EO-1428 | MAPK14; MAPK11 | P38 MAPK inhibitor | -- | Details |
| C15883 | BRD-K42453497 | BRD-K42453497 | -- | -- | -- | Details |
| C15884 | BRD-K42454450 | BRD-K42454450 | -- | -- | -- | Details |
| C15885 | BRD-K42455150 | BRD-K42455150 | -- | -- | -- | Details |
| C15886 | BRD-K42455540 | BRD-K42455540 | -- | -- | -- | Details |
| C15887 | BRD-K42455570 | BRD-K42455570 | -- | -- | -- | Details |
| C15888 | BRD-K42457027 | BRD-K42457027 | -- | -- | -- | Details |
| C15889 | BRD-K42465630 | BRD-K42465630 | -- | -- | -- | Details |
| C15890 | BRD-K42466986 | BRD-K42466986 | -- | -- | -- | Details |
| C15891 | BRD-K42470309 | BRD-K42470309 | -- | -- | -- | Details |
| C15892 | BRD-K42471691 | BRD-K42471691 | -- | -- | -- | Details |
| C15893 | BRD-K42475945 | BRD-K42475945 | -- | -- | -- | Details |
| C15894 | BRD-K42478399 | BRD-K42478399 | -- | -- | -- | Details |
| C15895 | BRD-K42478751 | BRD-K42478751 | -- | -- | -- | Details |
| C15896 | BRD-K42480393 | BRD-K42480393 | -- | -- | -- | Details |
| C15897 | BRD-K42482401 | BRD-K42482401 | -- | -- | -- | Details |
| C15898 | BRD-K42486494 | BRD-K42486494 | -- | -- | -- | Details |
| C15899 | BRD-K42486632 | BRD-K42486632 | -- | -- | -- | Details |
| C15900 | BRD-K42489623 | BRD-K42489623 | -- | -- | -- | Details |
| C15901 | BRD-K42495768 | tasisulam | -- | -- | -- | Details |
| C15902 | BRD-K42496940 | BRD-K42496940 | -- | -- | -- | Details |
| C15903 | BRD-K42499654 | BRD-K42499654 | -- | -- | -- | Details |